血小板豊富血漿市場：タイプ別、起源別、用途別、地域別

世界の血小板豊富血漿市場は、2025年には6億2,050万米ドルと推定され、2032年には14億3,370万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は12.7%で成長する見込みです。

図.血小板豊富血漿市場シェア（%）、2025年地域別

血小板豊富血漿（多血小板血漿）は、少量の全血から抽出した濃縮血小板です。多血小板血漿には、組織再生を促進することが知られている複数の成長因子が含まれています。多血小板血漿療法は、腱炎、関節損傷、関節炎などの様々な筋骨格系の症状に対する今後の治療法です。血小板からの成長因子の分泌は、幹細胞を引き寄せ、細胞の増殖と分化を刺激することによって、組織の治癒を誘導します。スポーツ外傷や変性疾患の有病率の増加に伴い、多血小板血漿は組織修復のための外科的介入や薬剤に代わる有望な選択肢として浮上しています。

市場力学

最近の動向は、その再生特性により、様々な治療セグメントで多血小板血漿が急速に採用されていることを示しています。スポーツ医療の成長と筋骨格系障害の症例増加は、この市場の主要促進要因です。しかし、多血小板血漿の手順や機器に関連するコストが高いことが、より広範な採用を抑制する可能性があります。安価な多血小板血漿調製キットの開発は大きな機会をもたらします。市場リーダーは、承認された臨床適応を拡大するために研究開発に投資しています。例えば、顔の若返りにおける多血小板血漿の使用に関する規制当局の承認は、新たな道を開くものです。

本調査の主要特徴

• 本レポートは、世界の多血小板血漿市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（100万米ドル）と複合年間成長率（CAGR%）を提供しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の多血小板血漿市場の主要企業をプロファイルしています。
• 主要企業は、Arthrex, Inc.、Ester Medical、Zimmer Biomet、Terumo Corporation、Glofinn Oy、Medira Ltd.、Regen Lab S.A.、CollPlant、Generex BIoTechnology Corporation、Estar Technologies Ltd.、Cesca Therapeutics, Inc.、Arteriocyte Medical Systems、Harvest Technologies Corp.、EmCyte Corporation、T-BIoTechnology Ltd.、Isto Biologicsです。
• このレポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 多血小板血漿の世界市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
• 利害関係者は、世界の多血小板血漿市場分析に使用される様々な戦略マトリックスを通じて意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• メーカー収益
• 買収と提携のシナリオ
• 製品の発売/承認
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の多血小板血漿市場-COVID-19パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の多血小板血漿市場、タイプ別、2020～2032年

• イントロダクション
• 純粋多血小板血漿
• 高白血球多血小板血漿
• 純粋多血小板フィブリン
• 多白血球多血小板フィブリン

第6章 世界の多血小板血漿市場、供給源別、2020～2032年

• イントロダクション
• 自家移植
• 同種異系
• 相同遺伝子

第7章 世界の多血小板血漿市場、用途別、2020～2032年

• イントロダクション
• 脳神経外科
• 美容整形
• 整形外科
• 一般外科
• その他

第8章 世界の多血小板血漿市場、地域別、2020～2032年

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Arthrex, Inc.
  • Ester Medical
  • Zimmer Biomet
  • Terumo Corporation
  • Glofinn Oy
  • Medira Ltd.
  • Regen Lab SA
  • CollPlant
  • Generex BIoTechnology Corporation
  • Estar Technologies Ltd.
  • Cesca Therapeutics, Inc.
  • Arteriocyte Medical Systems
  • Harvest Technologies Corp.
  • EmCyte Corporation
  • T-BIoTechnology Ltd.
  • Isto Biologics

第10章 アナリストの視点

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Platelet Rich Plasma Market is estimated to be valued at USD 620.5 Mn in 2025 and is expected to reach USD 1,433.7 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.7% from 2025 to 2032.

Figure. Platelet Rich Plasma Market Share (%), By Region 2025

Platelet Rich Plasma (PRP) is an enriched concentration of platelets extracted from a small volume of whole blood. It contains several growth factors that are known to accelerate tissue regeneration. PRP therapy is an upcoming treatment for various musculoskeletal conditions such as tendonitis, joint injuries, and arthritis. The secretion of growth factors from platelets induces tissue healing by attracting stem cells and stimulating cell proliferation and differentiation. With the increasing prevalence of sports injuries and degenerative conditions, PRP is emerging as a promising alternative to surgical interventions and medications for tissue repair.

Market Dynamics:

Recent trends indicate the rapid adoption of PRP in various therapeutic areas due to its regenerative properties. Growth in sports medicine and rising cases of musculoskeletal disorders are major drivers for this market. However, high costs associated with PRP procedures and equipment may restrain wider adoption. The development of inexpensive PRP preparation kits presents significant opportunities. Market leaders are investing in R&D to expand approved clinical indications. For example, regulatory approvals for use of PRP in facial rejuvenation opens new avenues.

Key Features of the Study:

• This report provides an in-depth analysis of the global platelet rich plasma market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global platelet rich plasma market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this Arthrex, Inc., Ester Medical, Zimmer Biomet, Terumo Corporation, Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology Corporation, Estar Technologies Ltd., Cesca Therapeutics, Inc., Arteriocyte Medical Systems, Harvest Technologies Corp., EmCyte Corporation, T-Biotechnology Ltd., and Isto Biologics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global platelet rich plasma market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global platelet rich plasma market.

Detailed Segmentation-

• By Type:
  • Pure PRP
  • Leukocyte rich PRP
  • Pure PRF
  • Leukocyte rich PRF
• By Origin:
  • Autologous
  • Allogenic
  • Homologues
• By Application:
  • Neurosurgery
  • Cosmetic Surgery
  • Orthopedic Surgery
  • General Surgery
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

Company Profiles:

• Arthrex, Inc.
• Ester Medical
• Zimmer Biomet
• Terumo Corporation
• Glofinn Oy
• Medira Ltd.
• Regen Lab S.A.
• CollPlant
• Generex Biotechnology Corporation
• Estar Technologies Ltd.
• Cesca Therapeutics, Inc.
• Arteriocyte Medical Systems
• Harvest Technologies Corp.
• EmCyte Corporation
• T-Biotechnology Ltd.
• Isto Biologics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Origin
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Platelet Rich Plasma Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Platelet Rich Plasma Market, By Type, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Pure PRP
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Leukocyte rich PRP
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Pure PRF
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Leukocyte rich PRF
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Platelet Rich Plasma Market, By Origin, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Autologous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Allogenic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Homologues
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Platelet Rich Plasma Market, By Application, 2020 - 2032, (USD Mn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Neurosurgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cosmetic Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Orthopedic Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• General Surgery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Platelet Rich Plasma Market, By Region, 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Origin, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • Arthrex, Inc.*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Ester Medical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Zimmer Biomet
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Glofinn Oy
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Medira Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Regen Lab S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • CollPlant
  • Generex Biotechnology Corporation
  • Estar Technologies Ltd.
  • Cesca Therapeutics, Inc.
  • Arteriocyte Medical Systems
  • Harvest Technologies Corp.
  • EmCyte Corporation
  • T-Biotechnology Ltd.
  • Isto Biologics

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"